Cargando…

New risk score for predicting progression of membranous nephropathy

BACKGROUND: Patients with Idiopathic membranous nephropathy (IMN) have various outcomes. The aim of this study is to construct a tool for clinicians to precisely predict outcome of IMN. METHODS: IMN patients diagnosed by renal biopsy from Shanghai Ruijin Hospital from 2009.01 to 2013.12 were enrolle...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiaofan, Hu, Jing, Xu, Chenni, Gao, Yifan, Wu, Xialian, Yu, Li, Lin, Hong, Ren, Wen, Zhang, Weiming, Wang, Xiaoxia, Pan, Jingyuan, Xie, Nan, Chen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368730/ https://www.ncbi.nlm.nih.gov/pubmed/30736804 http://dx.doi.org/10.1186/s12967-019-1792-8

Ejemplares similares

Predicting Progression of IgA Nephropathy: New Clinical Progression Risk Score
por: Xie, Jingyuan, et al.
Publicado: (2012)

Anti-glomerular basement membrane nephritis with bronchial carcinoma: a case report
por: Gao, Chenni, et al.
Publicado: (2019)

New risk score for predicting steroid resistance in patients with focal segmental glomerulosclerosis or minimal change disease
por: Weng, Qinjie, et al.
Publicado: (2020)

Membranous nephropathy associated with hepatitis C virus infection treated with corticosteroids and Ledipasvir-Sofosbuvir: a case report and review of literature
por: Weng, Qinjie, et al.
Publicado: (2017)

A Rare Genetic Defect of MBL2 Increased the Risk for Progression of IgA Nephropathy
por: Ouyang, Yan, et al.
Publicado: (2019)

Transthyretin-related hereditary amyloidosis with recurrent vomiting and renal insufficiency as the initial presentation: A case report
por: Xu, Jing, et al.
Publicado: (2017)

A validation study of crescents in predicting ESRD in patients with IgA nephropathy
por: Zhang, Xiaoyan, et al.
Publicado: (2018)

Biomarkers to detect membranous nephropathy in Chinese patients
por: Lin, Li, et al.
Publicado: (2016)

Underweight Is an Independent Risk Factor for Renal Function Deterioration in Patients with IgA Nephropathy
por: Ouyang, Yan, et al.
Publicado: (2016)

A Validation Study Comparing Risk Prediction Models of IgA Nephropathy
por: Ouyang, Yan, et al.
Publicado: (2021)

Prevalence of and risk factors for high-altitude hyperuricaemia in Bai individuals: a cross-sectional study
por: Gao, Chenni, et al.
Publicado: (2021)

Increased Lifetime Risk of ESRD in Familial IgA Nephropathy
por: Shi, Manman, et al.
Publicado: (2020)

Consolidation Treatment and Long-Term Prognosis of Rituximab in Minimal Change Disease and Focal Segmental Glomerular Sclerosis
por: Lin, Li, et al.
Publicado: (2021)

ABO blood type is associated with renal outcomes in patients with IgA nephropathy
por: Yang, Meng, et al.
Publicado: (2017)

Altered Expression of Long Noncoding and Messenger RNAs in Diabetic Nephropathy following Treatment with Rosiglitazone
por: Zhang, Liwen, et al.
Publicado: (2020)

Membranous Nephropathy with Rapid Progression
por: Vairakkani, R., et al.
Publicado: (2020)

An Unusual Progression of Membranous Nephropathy
por: Sharma, Arundhati, et al.
Publicado: (2022)

Develop and Validate a Risk Score in Predicting Renal Failure in Focal Segmental Glomerulosclerosis
por: Cai, Yikai, et al.
Publicado: (2023)

Clinical and genetic analysis of lipoprotein glomerulopathy patients caused by APOE mutations
por: Yang, Mingxin, et al.
Publicado: (2020)

Genotype: A Crucial but Not Unique Factor Affecting the Clinical Phenotypes in Fabry Disease
por: Pan, Xiaoxia, et al.
Publicado: (2016)

Membranous Nephropathy Associated with Tuberculosis
por: Shang, Ming-Hua, et al.
Publicado: (2016)

The role of cellular crosstalk in the progression of diabetic nephropathy
por: Zhang, Keying, et al.
Publicado: (2023)

Nomogram to predict the progression of patients with primary membranous nephropathy and nephrotic syndrome
por: Liu, Lili, et al.
Publicado: (2021)

Rituximab treatment in adults with refractory minimal change disease or focal segmental glomerulosclerosis
por: Ren, Hong, et al.
Publicado: (2017)

Characteristics of patients with coexisting IgA nephropathy and membranous nephropathy
por: Chen, Pei, et al.
Publicado: (2018)

Recent Progress in Deciphering the Etiopathogenesis of Primary Membranous Nephropathy
por: Kronbichler, Andreas, et al.
Publicado: (2017)

Microhematuria Enhances the Risks of Relapse and Renal Progression in Primary Membranous Nephropathy
por: He, Peng, et al.
Publicado: (2021)

Salivary microbiota analysis of patients with membranous nephropathy
por: Luan, Shaodong, et al.
Publicado: (2022)

Peritoneal-Pleural Leaks Demonstrated by CT Peritoneography
por: Xu, Tian, et al.
Publicado: (2015)

Asymptomatic Dialysate Turbidity and Repeated Intraductal Clots in a Peritoneal Dialysis Patient
por: Xu, Tian, et al.
Publicado: (2019)

The clinicopathological features of patients with membranous nephropathy
por: Zhu, Hanyu, et al.
Publicado: (2018)

Oral glucocorticoids with intravenous cyclophosphamide or oral glucocorticoids alone in the treatment of IgA nephropathy present with nephrotic syndrome and mesangioproliferative glomerulonephritis
por: Du, Wen, et al.
Publicado: (2023)

Successful Treatment of Idiopathic Eosinophilic Peritonitis by Oral Corticosteroid Therapy in a Continuous Ambulatory Peritoneal Dialysis Patient
por: Xu, Yaowen, et al.
Publicado: (2015)

Association of Nighttime Masked Uncontrolled Hypertension With Left Ventricular Hypertrophy and Kidney Function Among Patients with Chronic Kidney Disease Not Receiving Dialysis
por: Fu, Xiaocen, et al.
Publicado: (2022)

Clinical significance of plasma globotriaosylsphingosine levels in Chinese patients with Fabry disease
por: Ouyang, Yan, et al.
Publicado: (2018)

Smoking Is a Risk Factor for the Progression of Idiopathic Membranous Nephropathy
por: Yamaguchi, Makoto, et al.
Publicado: (2014)

Membranous Nephropathy
por: Mathieson, Peter
Publicado: (1997)

Membranous nephropathy
por: Dantas, Márcio, et al.
Publicado: (2023)

Validity of the SARC-F questionnaire in assessing sarcopenia in patients with chronic kidney disease: a cross-sectional study
por: Du, Wen, et al.
Publicado: (2023)

A regulatory role for CD72 expression on B cells and increased soluble CD72 in primary Sjogren’s syndrome
por: Shen, Yuqi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rcc86fj1nit6islj1daied1rgh